Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK

Published:2013-12-02 Issue:5 Volume:113 Page:748-753
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Dickinson Peter D.¹,Malik Jahangeer²,Mandall Paula¹,Swindell Ric¹,Bottomley David³,Hoskin Peter⁴,Logue John P.¹,Wylie James P.¹

Affiliation:

1. Department of Clinical Oncology; The Christie NHS Foundation Trust; Manchester UK

2. Department of Clinical Oncology; Edinburgh Cancer Centre; Edinburgh UK

3. Department of Clinical Oncology; Leeds Teaching Hospitals NHS Trust; Leeds UK

4. Department of Clinical Oncology; Mount Vernon Hospital; Northwood UK

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12358/fullpdf

Reference41 articles.

1. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I125 prostate brachytherapy in clinically localized prostate cancer: Seattle experience;Sylvester;Int J Radiat Oncol Biol Phys,2011

2. 10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients;Crook;Int J Radiat Oncol Biol Phys,2011

3. 10-year biochemical (prostate-specific antigen) control of prostate cancer with I125 brachytherapy;Grimm;Int J Radiat Oncol Biol Phys,2001

4. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer;Potters;J Urol,2005

5. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D'Amico;JAMA,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age;Journal of Contemporary Brachytherapy;2024

2. Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement;Brachytherapy;2021-11

3. Brachytherapy Combined With or Without Hormone Therapy for Localized Prostate Cancer: A Meta-Analysis and Systematic Review;Frontiers in Oncology;2020-02-19

4. Long-term biochemical outcomes using cesium-131 in prostate brachytherapy;Brachytherapy;2019-11

5. Long-term biochemical progression-free survival following brachytherapy for prostate cancer: Further insight into the role of short-term androgen deprivation and intermediate risk group subclassification;PLOS ONE;2019-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3